Endometriosis shows no impact on the euploid blastocyst rate per cohort of inseminated metaphase-II oocytes: A case-control study.


Journal

European journal of obstetrics, gynecology, and reproductive biology
ISSN: 1872-7654
Titre abrégé: Eur J Obstet Gynecol Reprod Biol
Pays: Ireland
ID NLM: 0375672

Informations de publication

Date de publication:
Jan 2021
Historique:
received: 18 08 2020
revised: 02 11 2020
accepted: 06 11 2020
pubmed: 28 11 2020
medline: 15 5 2021
entrez: 27 11 2020
Statut: ppublish

Résumé

To evaluate the true impact of endometriosis on oocytes' competence defined as blastulation, euploidy and implantation rates. Retrospective multicenter case-control study involving infertile couples undergoing ICSI with qPCR and trophectoderm biopsy-based PGT-A. Patients affected from endometriosis (n = 210) were diagnosed through transvaginal sonography or surgical history with histological confirmation. Each case was matched to two controls (n = 420) according to IVF clinic, maternal age at retrieval (38.6 ± 2.7 yr), number of previous failed IVF treatments (0.5 ± 0.8) and number of metaphase-II oocytes retrieved (6.1 ± 3.7 per patient). The primary outcome was the mean euploid blastocyst rate per cohort of inseminated metaphase-II oocytes. Other embryological, clinical, obstetric and neonatal outcomes were also evaluated. The mean euploid blastocyst rate per cohort of inseminated metaphase-II oocytes was identical in the two groups (18 %±22 %) independently of maternal age. No difference was shown for all embryological outcomes investigated. The live birth rates per vitrified-warmed single euploid blastocyst transfer were also similar (67/158, 42 % in patients affected from endometriosis versus 132/327, 40 % in matched-controls). No difference was reported in the gestational and neonatal outcomes. The cumulative live birth delivery rates among completed cycles were also identical (61/201, 30 % versus 117/391, 30 % in endometriosis and matched-control groups, respectively) independently of maternal age. Endometriosis might not impair oocyte developmental and reproductive competence, although its potential impact on the number of metaphase-II oocytes retrieved cannot be ignored. This information is critical for clinicians during counseling to outline an effective strategy to treat infertile patients affected from this condition. Future prospective studies are needed to evaluate the impact of endometriosis stage on euploidy rates.

Identifiants

pubmed: 33246206
pii: S0301-2115(20)30735-1
doi: 10.1016/j.ejogrb.2020.11.024
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

205-210

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors report no declarations of interest.

Auteurs

Alberto Vaiarelli (A)

Clinica Valle Giulia, GENERA Centers for Reproductive Medicine, Rome, Italy.

Roberta Venturella (R)

Magna Graecia University, Department of Experimental and Clinical Medicine, ART Center, Catanzaro, Italy. Electronic address: venturella@unicz.it.

Danilo Cimadomo (D)

Clinica Valle Giulia, GENERA Centers for Reproductive Medicine, Rome, Italy; GENERA Veneto, GENERA Centers for Reproductive Medicine, Marostica, Italy; Clinica Ruesch, GENERA Centers for Reproductive Medicine, Naples, Italy.

Alessandro Conforti (A)

University "Federico II" of Naples, Department of Neuroscience, Reproductive Science and Odontostomatology, Italy.

Sara Pedri (S)

Magna Graecia University, Department of Experimental and Clinical Medicine, ART Center, Catanzaro, Italy.

Giovanna Bitonti (G)

Magna Graecia University, Department of Experimental and Clinical Medicine, ART Center, Catanzaro, Italy.

Benedetta Iussig (B)

GENERA Veneto, GENERA Centers for Reproductive Medicine, Marostica, Italy.

Cinzia Gentile (C)

GENERA Veneto, GENERA Centers for Reproductive Medicine, Marostica, Italy.

Erminia Alviggi (E)

Clinica Ruesch, GENERA Centers for Reproductive Medicine, Naples, Italy.

Serena Santopaolo (S)

Clinica Ruesch, GENERA Centers for Reproductive Medicine, Naples, Italy.

Fulvio Zullo (F)

Magna Graecia University, Department of Experimental and Clinical Medicine, ART Center, Catanzaro, Italy; University "Federico II" of Naples, Department of Neuroscience, Reproductive Science and Odontostomatology, Italy.

Laura Rienzi (L)

Clinica Valle Giulia, GENERA Centers for Reproductive Medicine, Rome, Italy; GENERA Veneto, GENERA Centers for Reproductive Medicine, Marostica, Italy; Clinica Ruesch, GENERA Centers for Reproductive Medicine, Naples, Italy.

Filippo Maria Ubaldi (FM)

Clinica Valle Giulia, GENERA Centers for Reproductive Medicine, Rome, Italy; GENERA Veneto, GENERA Centers for Reproductive Medicine, Marostica, Italy; Clinica Ruesch, GENERA Centers for Reproductive Medicine, Naples, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH